Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2010, Vol. 11 Issue (4): 227-237    DOI: 10.1631/jzus.B0900327
Biomedicine     
Urinary proteomics as a novel tool for biomarker discovery in kidney diseases
Jing Wu, Yi-ding Chen, Wei Gu
Department of Endocrinology and Metabolism, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China, Department of Oncology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Urine has become one of the most attractive biofluids in clinical proteomics, for its procurement is easy and noninvasive and it contains sufficient proteins and peptides. Urinary proteomics has thus rapidly developed and has been extensively applied to biomarker discovery in clinical diseases, especially kidney diseases. In this review, we discuss two important aspects of urinary proteomics in detail, namely, sample preparation and proteomic technologies. In addition, data mining in urinary proteomics is also briefly introduced. At last, we present several successful examples on the application of urinary proteomics for biomarker discovery in kidney diseases, including diabetic nephropathy, IgA nephropathy, lupus nephritis, renal Fanconi syndrome, acute kidney injury, and renal allograft rejection.

Key wordsClinical proteomics      Urinary proteomics      Biomarker      Kidney diseases     
Received: 20 October 2009      Published: 29 March 2010
CLC:  R57  
  R58  
Cite this article:

Jing Wu, Yi-ding Chen, Wei Gu. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(4): 227-237.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B0900327     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2010/V11/I4/227

[1] Sabrina Mattoli. Pathogenetic and prognostic roles of bloodborne fibrocytes in asthma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(8): 651-660.
[2] Darren S. Miller, Anne Michelle Parsons, John Bresland, Paul Herde, Duc Minh Pham, Angel Tan, Hung-yao Hsu, Clive A. Prestidge, Tim Kuchel, Rezaul Begg, Syed Mahfuzul Aziz, Ross N. Butler. A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(7): 586-592.
[3] Li Min, Jian-bo Cheng, Bao-lu Shi, Hong-jian Yang, Nan Zheng, Jia-qi Wang. Effects of heat stress on serum insulin, adipokines, AMP-activated protein kinase, and heat shock signal molecules in dairy cows[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(6): 541-548.
[4] Ying-ying Lu, Xian Yang, Wen-qing Chen, Zhen-yu Ju, Zhang-fei Shou, Juan Jin, Xiao-hui Zhang, Jiang-hua Chen, Hong Jiang. Proteins induced by telomere dysfunction are associated with human IgA nephropathy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 566-574.
[5] Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha. Prostate cancer: the need for biomarkers and new therapeutic targets[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 16-42.
[6] Wei-qin Jiang, Fang-fang Fu, Yang-xia Li, Wei-bin Wang, Hao-hao Wang, Hai-ping Jiang, Li-song Teng. Molecular biomarkers of colorectal cancer: prognostic and predictive tools for clinical practice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(9): 663-675.
[7] Xiao-hui Zhai, Jie-kai Yu, Chen Lin, Li-dong Wang, Shu Zheng. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(12): 964-971.
[8] Li Yang, Min Lin, Wen-jing Ruan, Liang-liang Dong, En-guo Chen, Xiao-hong Wu, Ke-jing Ying. Nkx2-1: a novel tumor biomarker of lung cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 855-866.
[9] Jun ZHANG, Xin-you XIE, Su-wen YANG, Jin WANG, Chao HE. Nicotinamide N-methyltransferase protein expression in renal cell cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(2): 136-143.
[10] Yong MAO, Xin HUANG, Ke YU, Hai-bin QU, Chang-xiao LIU, Yi-yu CHENG. Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 474-481.
[11] Li-rong ZHU, Wen-ying ZHANG, Li YU, Yan-hua ZHENG, Jun HU, Qin-ping LIAO. Proteiomic patterns for endometrial cancer using SELDI-TOF-MS[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(4): 286-290.
[12] Hussain MONTAZERY-KORDY, Mohammad Hossein MIRAN-BAYGI, Mohammad Hassan MORADI. A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(11): 863-870.
[13] GRIZZI Fabio, FRANCESCHINI Barbara, FIAMENGO Barbara, RUSSO Carlo, DIOGUARDI Nicola. Vascular architecture: is it a helpful histopathological biomarker for hepatocellular carcinoma?[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(4): 217-220.
[14] ZOU Yang-yun, YANG Jian, ZHU Jun. A robust statistical procedure to discover expression biomarkers using microarray genomic expression data[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2006, 7(8 ): 1-.
[15] ALAOUI-JAMALI Moulay A., XU Ying-jie. Proteomic technology for biomarker profiling in cancer: an update[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2006, 7(6 ): 1-.